1. Home
  2. ELTX vs FRD Comparison

ELTX vs FRD Comparison

Compare ELTX & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • FRD
  • Stock Information
  • Founded
  • ELTX 2011
  • FRD 1965
  • Country
  • ELTX United States
  • FRD United States
  • Employees
  • ELTX N/A
  • FRD N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • FRD Steel/Iron Ore
  • Sector
  • ELTX Health Care
  • FRD Industrials
  • Exchange
  • ELTX Nasdaq
  • FRD Nasdaq
  • Market Cap
  • ELTX 121.7M
  • FRD 115.9M
  • IPO Year
  • ELTX N/A
  • FRD N/A
  • Fundamental
  • Price
  • ELTX $8.05
  • FRD $16.71
  • Analyst Decision
  • ELTX Strong Buy
  • FRD
  • Analyst Count
  • ELTX 2
  • FRD 0
  • Target Price
  • ELTX $9.50
  • FRD N/A
  • AVG Volume (30 Days)
  • ELTX 51.5K
  • FRD 19.5K
  • Earning Date
  • ELTX 08-12-2025
  • FRD 06-12-2025
  • Dividend Yield
  • ELTX N/A
  • FRD 0.98%
  • EPS Growth
  • ELTX N/A
  • FRD N/A
  • EPS
  • ELTX N/A
  • FRD 0.87
  • Revenue
  • ELTX N/A
  • FRD $444,600,000.00
  • Revenue This Year
  • ELTX N/A
  • FRD N/A
  • Revenue Next Year
  • ELTX N/A
  • FRD N/A
  • P/E Ratio
  • ELTX N/A
  • FRD $18.98
  • Revenue Growth
  • ELTX N/A
  • FRD N/A
  • 52 Week Low
  • ELTX $3.34
  • FRD $12.24
  • 52 Week High
  • ELTX $9.99
  • FRD $19.12
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 63.45
  • FRD 52.72
  • Support Level
  • ELTX $7.76
  • FRD $16.12
  • Resistance Level
  • ELTX $8.10
  • FRD $17.27
  • Average True Range (ATR)
  • ELTX 0.60
  • FRD 0.67
  • MACD
  • ELTX -0.03
  • FRD -0.02
  • Stochastic Oscillator
  • ELTX 54.76
  • FRD 51.26

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About FRD Friedman Industries Inc.

Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.

Share on Social Networks: